ResearcherUniversity of MinnesotaActive in the last 2 years

Daniel A. Saltzman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9583-300X; OpenAlex author ID A5002271024. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

A phase 2 study of orally administered live biotherapeutic salmonella-IL2 with FOLFIRINOX for stage IV pancreatic cancer. Last author DOI 10.1007/s00262-026-04307-0 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gerald Batist · 1 shared paper, 2026 · strength 0.33
- Paper A phase 2 study of orally administered live biotherapeutic salmonella-IL2 with FOLFIRINOX for stage IV pancreatic cance… DOI 10.1007/s00262-026-04307-0 ↗
Petr Kavan · 1 shared paper, 2026 · strength 0.33
- Paper A phase 2 study of orally administered live biotherapeutic salmonella-IL2 with FOLFIRINOX for stage IV pancreatic cance… DOI 10.1007/s00262-026-04307-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.